Abstract:Osteoarthritis (OA) is a common debilitating disease affecting articular joints for which no effective disease-modifying early diagnosis or medical therapy tools are currently available. The inefficient delivery of drugs into inflamed chondrocytes has restricted the development of anti-OA medication. Evidence has shown that inflammatory neutrophils possess the property of targeting inflammation via inflammatory tissue recruiting. Herein, we report neutrophil-cell-membrane-based biomimetic nanoparticles (NM-LANPs@Ru) as an OA theranostic nanoplatform; they act as a NO delivery system, coating neutrophil cell membrane onto the surface of self-assembled PEGylated L -arginine nanoparticles (LANPs) to act as a NO donor and loading a Ru complex to act as a ROS inducer. NM-LANPs@Ru demonstrated the specific targeting of inflamed OA with low toxicity, good NO release, and excellent fluorescence/photoacoustic (FL/PA) imaging properties. We showed that NM-LANPs@Ru exhibited enhanced cellular association in inflamed chondrocyte cells (C28/I2), much higher than NO release from ROS oxidized LA, and it improved the inhibition of the apoptosis of inflamed C28/I2 cells compared with control treatments. In vivo studies demonstrated that NM-LANPs@Ru effectively targeted inflamed OA, based on real-time dual-modal FL/PA imaging, eventually exhibiting its excellent anti-inflammatory activity. Our study may provide a new approach for the early diagnosis and treatment of osteoarthritis using a neutrophil-cell-membrane-based biomimetic nanoplatform for NO or drug delivery.

A nitric oxide responsive AIE probe for detecting the progression of osteoarthritis

A robust NIR fluorescence-activated probe for peroxynitrite imaging in cells and mice osteoarthritis models

Detection of Matrix Metallopeptidase 13 for Monitoring Stem Cell Differentiation and Early Diagnosis of Osteoarthritis by Fluorescent Light-Up Probes with Aggregation-Induced Emission Characteristics

A biomarker (ONOO-)-activated multicolor fluorescent probe for early detection and assessment of arthritis

A near-infrared fluorescent probe for imaging peroxynitrite levels in paw edema mice and drug evaluation

Mitochondrial-Targeted Ratiometric Near-Infrared Fluorescence Probe for Monitoring Nitric Oxide in Rheumatoid Arthritis

Sensitive and specific detection of peroxynitrite and in vivo imaging of inflammation by a “simple” AIE bioprobe

Refashioning benzothiadiazole dye as an activatable nanoprobe for biomarker detection with NIR-II fluorescence/optoacoustic imaging

A novel fast-response and highly selective AIEgen fluorescent probe for visualizing peroxynitrite in living cells, C. elegans and inflammatory mice

Peroxynitrite-activated Fluorescent Probe with Two Reaction Triggers for Pathological Diagnosis and Therapeutic Evaluation of Inflammation

An easily available ratiometric AIE probe for nitroxyl visualization <i>in vitro</i> and <i>in vivo</i>

A neutrophil cell membrane-biomimetic nanoplatform based on L-arginine nanoparticles for early osteoarthritis diagnosis and nitric oxide therapy

Intelligent dual responsive modified ZIF-8 nanoparticles for diagnosis and treatment of osteoarthritis

An electronic-tuning strategy to improve the responsiveness of nitric oxide probe

Reactive oxygen species (ROS)-responsive nanoprobe for bioimaging and targeting therapy of osteoarthritis

An N-Nitrosation Reactivity-Based Two-Photon Fluorescent Probe for the Specific in Situ Detection of Nitric Oxide

An Activatable Fluorescent Probe for Imaging Endogenous Nitric Oxide Via the Enos Enzymatic Pathway

An easily available ratiometric AIE probe for nitroxyl visualization in vitro and in vivo

Engineering Fluorescent NO Probes for Live-Monitoring Cellular Inflammation and Apoptosis

A rapid VEGF-gene-sequence photoluminescence detector for osteoarthritis

Highly Sensitive Near-Infrared Imaging Of Peroxynitrite Fluxes In Inflammation Progress